KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • Innovation to impact – Introducing new drugs and shorter drug regimens

    Photo: Pharmacovigilance workshop, Tajikistan, December 2015. Current treatment of multidrug-resistant forms of TB (MDR-TB) requires the use of multiple…

    Lees meer
  • 15/01/2016

    Panel debate: From Innovation to Impact

    On January 26, KIT and KNCV hosted the panel debate ‘From Innovation to Impact’. Guest speakers included Mr. Hans Rosling…

    Lees meer
  • 12/01/2016

    Nigeria Minister of Health reaffirms support to KNCV/Challenge TB

    Our support to TB control in Nigeria is the largest KNCV/Challenge TB project in Africa. The Honorable Minister of Health,…

    Lees meer
  • National Implementation of GxAlert in Botswana – integrated patient data management

    TB data management through the GxAlert initiative Integrated patient data management through the GxAlert initiative KNCV has supported the national…

    Lees meer
  • 07/01/2016

    Launch of the US National Action Plan for Combating MDR-TB

    On January 7, USAID will officially launch the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis (MDR-TB). On December…

    Lees meer
  • 18/12/2015

    Further decline of TB in the Netherlands in 2014.

    last century TB house – Zonnestraal The latest data on tuberculosis in the Netherlands in 2014 have been published…

    Lees meer
  • 03/12/2015

    Union 2015: Launch of self-assessment benchmarking tool for Childhood TB

    On Thursday 3 December, KNCV presented its Benchmarking tool for Childhood TB policies, practice and planning to the…

    Lees meer
  • Control of TB among people with HIV/AIDS in Nigeria

    Under the auspices of the National AIDS Control Agency in Nigeria (NACA) we are leading a team that is building…

    Lees meer
  • Supporting the introduction of GeneXpert in Nigeria

    The Xpert MTB/RIF diagnostic test has tremendous potential for improving tuberculosis (TB) diagnostic capacity in countries with a high burden…

    Lees meer
  • Nigeria: Start of the Challenge TB project

    On August 12, 2015 the Challenge TB project in Nigeria was launched. This project, which succeeds the TB CARE…

    Lees meer
  • Karel Styblo Award for Maarten van Cleeff

    Dr. Maarten van Cleeff has been presented with the Karel Styblo Public Health Prize at the Opening Ceremony of the…

    Lees meer
  • 27/11/2015

    Member of Board of Trustees reappointed to permanent European Integration Committee

    KNCV Tuberculosis Foundation is delighted to learn that Mirella C.B. Visser (LLM) has been reappointed by…

    Lees meer
  • 12/11/2015

    Prestigious new post for Frank Cobelens

    Today, it was announced that Frank Cobelens, Scientific Director at KNCV Tuberculosis Foundation, is to become the new Chairman of…

    Lees meer
  • 03/11/2015

    KNCV signs Bali Declaration

    On November 3rd 2015, KNCV Tuberculosis Foundation signed the Bali Declaration, at the close of the first Global…

    Lees meer
  • 02/11/2015

    Global Summit on Diabetes and Tuberculosis

    KNCV’s Chief Executive Officer Kitty van Weezenbeek together with National TB Program (NTP) Manager Dr. Christina Widaningrum and colleagues in…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.